87 related articles for article (PubMed ID: 26056942)
21. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
22. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
23. Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells.
Guo P; Dong XY; Zhao KW; Sun X; Li Q; Dong JT
Int J Cancer; 2010 Jan; 126(1):81-9. PubMed ID: 19569049
[TBL] [Abstract][Full Text] [Related]
24. Estrogen-related receptor alpha is critical for the growth of estrogen receptor-negative breast cancer.
Stein RA; Chang CY; Kazmin DA; Way J; Schroeder T; Wergin M; Dewhirst MW; McDonnell DP
Cancer Res; 2008 Nov; 68(21):8805-12. PubMed ID: 18974123
[TBL] [Abstract][Full Text] [Related]
25. Effect of Hispolon from Phellinus lonicerinus (Agaricomycetes) on Estrogen Receptors, Aromatase, and Cyclooxygenase II in MCF-7 Breast Cancer Cells.
Wang J; Chen B; Hu F; Zou X; Yu H; Wang J; Zhang H; He H; Huang W
Int J Med Mushrooms; 2017; 19(3):233-242. PubMed ID: 28605338
[TBL] [Abstract][Full Text] [Related]
26. Effects of hispolon on glioblastoma cell growth.
Arcella A; Oliva MA; Sanchez M; Staffieri S; Esposito V; Giangaspero F; Cantore G
Environ Toxicol; 2017 Sep; 32(9):2113-2123. PubMed ID: 28618133
[TBL] [Abstract][Full Text] [Related]
27. Isothiocyanates repress estrogen receptor alpha expression in breast cancer cells.
Kang L; Ding L; Wang ZY
Oncol Rep; 2009 Jan; 21(1):185-92. PubMed ID: 19082460
[TBL] [Abstract][Full Text] [Related]
28. Hispolon from Phellinus linteus possesses mediate caspases activation and induces human nasopharyngeal carcinomas cells apoptosis through ERK1/2, JNK1/2 and p38 MAPK pathway.
Hsieh MJ; Chien SY; Chou YE; Chen CJ; Chen J; Chen MK
Phytomedicine; 2014 Oct; 21(12):1746-52. PubMed ID: 25442286
[TBL] [Abstract][Full Text] [Related]
29. Nucleo-cytoplasmic transport of estrogen receptor alpha in breast cancer cells.
Tecalco-Cruz AC; Pérez-Alvarado IA; Ramírez-Jarquín JO; Rocha-Zavaleta L
Cell Signal; 2017 Jun; 34():121-132. PubMed ID: 28341599
[TBL] [Abstract][Full Text] [Related]
30. Hispolon inhibits breast cancer cell migration by reversal of epithelial-to-mesenchymal transition via suppressing the ROS/ERK/Slug/E-cadherin pathway.
Zhao Z; Sun YS; Chen W; Lv LX; Li YQ
Oncol Rep; 2016 Feb; 35(2):896-904. PubMed ID: 26718128
[TBL] [Abstract][Full Text] [Related]
31. Elucidating the anti-melanoma effect and mechanisms of Hispolon.
Al Saqr A; Majrashi M; Alrbyawi H; Govindarajulu M; Fujihashi A; Gottumukkala S; Poudel I; Arnold RD; Babu RJ; Dhanasekaran M
Life Sci; 2020 Sep; 256():117702. PubMed ID: 32387411
[TBL] [Abstract][Full Text] [Related]
32. Hispolon Induces Apoptosis, Suppresses Migration and Invasion of Glioblastoma Cells and Inhibits GBM Xenograft Tumor Growth In Vivo.
Liao KF; Chiu TL; Chang SF; Wang MJ; Chiu SC
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361649
[TBL] [Abstract][Full Text] [Related]
33. Hispolon induces apoptosis against prostate DU145 cancer cells via modulation of mitochondrial and STAT3 pathways.
Masood M; Rasul A; Sarfraz I; Jabeen F; Liu S; Liu X; Wei W; Li J; Li X
Pak J Pharm Sci; 2019 Sep; 32(5(Supplementary)):2237-2243. PubMed ID: 31894049
[TBL] [Abstract][Full Text] [Related]
34. Phloretin Inhibits the Proliferation of Breast Cancer Cells Through the Down-regulation of Estrogen Receptor α.
Jang SY; Kim J; Hong E; Yang YJ; Na Y; Yeom CH; Park S
Anticancer Res; 2024 Mar; 44(3):1109-1120. PubMed ID: 38423666
[TBL] [Abstract][Full Text] [Related]
35. Anticancer Perspectives on the Fungal-Derived Polyphenolic Hispolon.
Islam MT; Ali ES; Khan IN; Shaw S; Uddin SJ; Rouf R; Dev S; Saravi SSS; Das N; Tripathi S; Yele SU; Das AK; Shilpi JA; Mishra SK; Mubarak MS
Anticancer Agents Med Chem; 2020; 20(14):1636-1647. PubMed ID: 32560616
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in peptidomimetics antagonists targeting estrogen receptor α-coactivator interaction in cancer therapy.
Qin W; Xie M; Qin X; Fang Q; Yin F; Li Z
Bioorg Med Chem Lett; 2018 Sep; 28(17):2827-2836. PubMed ID: 30025900
[TBL] [Abstract][Full Text] [Related]
37. Hispolon: A natural polyphenol and emerging cancer killer by multiple cellular signaling pathways.
Sarfraz A; Rasul A; Sarfraz I; Shah MA; Hussain G; Shafiq N; Masood M; Adem Ş; Sarker SD; Li X
Environ Res; 2020 Nov; 190():110017. PubMed ID: 32768475
[TBL] [Abstract][Full Text] [Related]
38. Aminophenols increase proliferation of thyroid tumor cells by inducing the transcription factor activity of estrogen receptor α.
Wang L; Zhao L; Jia X; Jiang L; Song Y; Ye Q; Lyu Z
Biomed Pharmacother; 2019 Jan; 109():621-628. PubMed ID: 30399599
[TBL] [Abstract][Full Text] [Related]
39. Developing Hispolon-based novel anticancer therapeutics against human (NF-κβ) using
Paul M; Kumar Panda M; Thatoi H
J Biomol Struct Dyn; 2019 Sep; 37(15):3947-3967. PubMed ID: 30295165
[TBL] [Abstract][Full Text] [Related]
40. SHARPIN stabilizes estrogen receptor α and promotes breast cancer cell proliferation.
Zhuang T; Yu S; Zhang L; Yang H; Li X; Hou Y; Liu Z; Shi Y; Wang W; Yu N; Li A; Li X; Li X; Niu G; Xu J; Hasni MS; Mu K; Wang H; Zhu J
Oncotarget; 2017 Sep; 8(44):77137-77151. PubMed ID: 29100376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
